{"id":"NCT01323634","sponsor":"GlaxoSmithKline","briefTitle":"Study to Evaluate the 24-Hour Pulmonary Function Profile of Fluticasone Furoate (FF) /GW642444 (Vilanterol) (VI) Inhalation Powder 100/25mcg Once Daily Compared With Fluticasone Propionate/Salmeterol Inhalation Powder 250/50mcg Twice Daily in Subjects With Chronic Obstructive Pulmonary Disease","officialTitle":"A 12-week Study to Evaluate the 24-hour Pulmonary Function Profile of Fluticasone Furoate/Vilanterol (FF/VI) Inhalation Powder 100/25 mcg Once Daily Compared With Fluticasone Propionate/Salmeterol Inhalation Powder 250/50 mcg Twice Daily in Subjects With Chronic Obstructive Pulmonary Disease (COPD)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-03-18","primaryCompletion":"2011-12-14","completion":"2011-12-14","firstPosted":"2011-03-25","resultsPosted":"2013-07-30","lastUpdate":"2017-11-08"},"enrollment":519,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Pulmonary Disease, Chronic Obstructive"],"interventions":[{"type":"DRUG","name":"Fluticasone Furoate 100mcg / GW642444 (vilanterol) 25mcg","otherNames":[]},{"type":"DRUG","name":"Fluticasone Propionate 250mcg/ salmeterol 50mcg","otherNames":[]}],"arms":[{"label":"Fluticasone Furoate / GW642444 (vilanterol)","type":"EXPERIMENTAL"},{"label":"Fluticasone Propionate / salmeterol","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to evaluate the 24-hour spirometry effect (FEV1) of FF/VI 100/25mcg once daily compared with Fluticasone Propionate/Salmeterol 250/50mcg twice daily over a 12-week treatment period in subjects with COPD.","primaryOutcome":{"measure":"Change From Baseline Trough in 24-hour Weighted-mean FEV1 on Treatment Day 84","timeFrame":"Baseline (Day 1) and Day 84","effectByArm":[{"arm":"FSC 250/50 µg BID","deltaMin":0.094,"sd":0.0158},{"arm":"FF/VI 100/25 µg QD","deltaMin":0.174,"sd":0.0153}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"40 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":19},"locations":{"siteCount":50,"countries":["United States","Czechia","Germany","Poland","Romania","Russia"]},"refs":{"pmids":["24998880"],"seeAlso":["https://www.clinicalstudydatarequest.com"]},"adverseEventsSummary":{"seriousAny":{"events":8,"n":259},"commonTop":["Headache","Nasopharyngitis"]}}